Bayer Acquires German Biotech Start-up Targenomix
Bayer AG | Monheim, Nov. 10, 2022 | Targenomix, a spin-off of the Max Planck Institute for Molecular Plant Physiology, will contribute to Bayer’s Crop Science R&D pipeline by continuing to deliver novel systems biology approaches for innovative crop protection discovery / Targenomix will continue its start-up approach as a standalone entity wholly-owned by Bayer
Read more